Biosimilar Newsletter Archive

41. 02.06.25 -- Developing ADCs? A Refresher On HPAPI Occupational Health Risk Mitigation 2/6/2025
    02/06/25 Biosimilar Development Newsletter
42. 01.30.25 -- New Regulatory Survey Findings: Biotech Market Access Challenges 1/30/2025
    01/30/25 Biosimilar Development Newsletter
43. 01.23.25 -- How To Establish A Win-Win Relationship With Your CDMO 1/23/2025
    01/23/25 Biosimilar Development Newsletter
44. 01.16.25 -- Become A cGMP "Special Agent" With A License To Care 1/16/2025
    01/16/25 Biosimilar Development Newsletter
45. 01.09.25 -- AP Biosciences' Approach To Complex Antibody Manufacturing 1/9/2025
    01/09/25 Biosimilar Development Newsletter
46. 01.02.25 -- Cell Culture Trends To Watch In 2025 1/2/2025
    01/02/25 Biosimilar Development Newsletter
47. 12.19.24 -- How To Ensure 21 CFR Part 11 Compliance 12/19/2024

    12/19/24 Biosimilar Development Newsletter

48. 12.19.24 -- 4 Technologies To Transform The Supply Chain in 2025 12/19/2024
    12/19/24 Biosimilar Development Newsletter
49. 12.15.24 -- Is The BIOSECURE Act The First Real Step Toward Reshoring? 12/15/2024
    12/15/24 Biosimilar Development Newsletter
50. 12.13.24 -- All Eyes On Sustainability 12/13/2024

    12/13/24 Biosimilar Development Newsletter